首页> 外国专利> METHODS AND COMPOSITIONS FOR PROGNOSTIC RISK ANALYSIS OF CLEAR CELL RENAL CELL CARCINOMA

METHODS AND COMPOSITIONS FOR PROGNOSTIC RISK ANALYSIS OF CLEAR CELL RENAL CELL CARCINOMA

机译:透明细胞肾细胞癌预后风险分析的方法和成分

摘要

Provided are methods for distinguishing clear cell type A (ccA) renal cell carcinoma from clear cell type B (ccB) renal cell carcinoma in a subject. In some embodiments, the method include the steps of obtaining a biological sample from a subject that has clear cell renal cell carcinoma (ccRCC); assaying the biological sample to determine an expression level for one or more and optionally all thirty-four of the gene products listed in Table 1 in the biological sample; and comparing the expression level(s) determined to a statistically validated reference. Also provided are methods for generating prognostic signatures for subject with ccRCC, methods for assessing risk of an adverse outcome of a subject with ccRCC, methods for predicting a clinical outcome of a treatment in a subject having ccRCC, and arrays that can be employed in the practice of the presently disclosed methods.
机译:提供了在受试者中区分透明细胞A型(ccA)肾细胞癌和透明细胞B型(ccB)肾细胞癌的方法。在一些实施方案中,该方法包括从患有透明细胞肾细胞癌(ccRCC)的受试者获得生物样品的步骤;分析该生物样品以确定该生物样品中表1中所列的一种或多种以及任选地所有三十四种基因产物的表达水平;并将确定的表达水平与经统计验证的参考进行比较。还提供了产生具有ccRCC的受试者的预后签名的方法,评估具有ccRCC的受试者的不良结局的风险的方法,用于预测具有ccRCC的受试者的治疗的临床结果的方法,以及可用于该研究的阵列。当前公开的方法的实践。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号